Cleared Traditional

K252592 - TELLTALE Electrosurgical Guidewire System (FDA 510(k) Clearance)

Nov 2025
Decision
90d
Days
Class 2
Risk

K252592 is an FDA 510(k) clearance for the TELLTALE Electrosurgical Guidewire System. This device is classified as a Percutaneous Catheter For Electrosurgical Cutting Heart Valve Leaflets Concomitant To Transcatheter Valve Procedures (Class II - Special Controls, product code SGO).

Submitted by Telltale, LLC (Andover, US). The FDA issued a Cleared decision on November 13, 2025, 90 days after receiving the submission on August 15, 2025.

This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1254. The Device Is Intended For Electrosurgically Splitting Valve Leaflets To Facilitate A Planned Valvular Procedure.

Submission Details

510(k) Number K252592 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 15, 2025
Decision Date November 13, 2025
Days to Decision 90 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code SGO - Percutaneous Catheter For Electrosurgical Cutting Heart Valve Leaflets Concomitant To Transcatheter Valve Procedures
Device Class Class II - Special Controls
CFR Regulation 21 CFR 870.1254
Definition The Device Is Intended For Electrosurgically Splitting Valve Leaflets To Facilitate A Planned Valvular Procedure